SCHEMBL9178238

SCHEMBL9178238

c1ccc2c(c1)C[C@@H]2CCN1CCN(c2cccc3c2CCOO3)CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1037294 1.00
SCHEMBL9467335 0.94 DRD2 (0.45)
SCHEMBL9176453 0.94 DRD2 (0.45)
SCHEMBL9177231 0.93 DRD4 (0.46)
SCHEMBL9180749 0.93 DRD4 (0.46)
SCHEMBL1038532 0.92 HTR2C (0.44)
SCHEMBL9175625 0.92 HTR2C (0.44)
SCHEMBL9466299 0.90 SIGMAR1 (0.47)
SCHEMBL9175522 0.90 SIGMAR1 (0.47)
SCHEMBL9182178 0.89 HTR2C (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0490772-B1 1,4-Disubstituted piperazines, their process of preparation and pharmaceutical compositions containing them ADIR (FR) 1995-07-26 EP claimed
US-5194437-A Substituted with oxygen containing heterocycle, central nervous system disorders, neuroendocrine disorders ADIR ET COMPAGNIE (FR) 1993-03-16 US claimed
JP-6025217-A None JP disclosed
JP-H0625217-A NEW 1,4-DISUBSTITUTED PIPERAZINE ADIR 1994-02-01 JP disclosed
US-5194437-A Substituted with oxygen containing heterocycle, central nervous system disorders, neuroendocrine disorders ADIR ET COMPAGNIE (FR) 1993-03-16 US disclosed